Welcome to EPG Patient Direct

The healthcare portal for patients and the general public in Europe

Welcome
  • Conditions and illnesses
  • Managing your health
  • Lifestyle advice
  • Treatment choices

Your Vote

Are you affected by second- hand smoke?
Yes
No

To read more about second hand smoke please click here

This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.

   

More NewsEPG Patient Direct News

Researchers to trial new GERD treatment

09 Jul 2008

The Council for Scientific and Industrial Research (CSIR) in South Africa has developed a new injectable treatment to be trialled for patients with gastroesophageal reflux disease (GERD).

At present, the options available to GERD sufferers include expensive medication or invasive surgery.

Researchers at the CSIR have now developed an injection designed to be administered using an endoscopic needle.

One of the inventors of this novel treatment, Kersch Naidoo, explained that the injection aims to restore muscle function of the lower oesophagus, in order to prevent gastric reflux causing chronic heartburn.

In addition to long-term discomfort, people who suffer from GERD are more at risk of developing cancer of the oesophagus.

Studies have shown that certain foods can promote gastroesophageal reflux, including coffee, alcohol and excessive amounts of the dietary supplement vitamin C.

According to EGS Europe, GERD can also lead to a variety of complications including anaemia, coughing, asthma and recurrent bronchitis.

Click here to visit the Reflux Disease Quick GuideADNFCR-1528-ID-18676045-ADNFCR

Email article E-mail    Bookmark Bookmark    Print Article Print

Delicious   Reddit Reddit   Facebook Facebook   StumbleUpon StumbleUpon  

Related News Stories (GERD (Gastroesophageal Reflux Disease))